in addition to the withdrawal from the sec executed by the

New Post Public Reply Private Reply Replies (1) Message Board
microcaps ears #5798
643
in addition to the withdrawal from the sec executed by the former infetech, as explained by mits, NNLX ha to confront the tradeoffs noted below

btw,the number of shareholders, along with other min requirements, are minimum requirements to join a big board -they dont force a company to do so!

from the last cite you've posted re this subject:

"Consider whether cost avoidance is a legitimate driver. Publicly traded companies spend a lot of time and money maintaining the standards required by the national stock exchanges and the SEC. The costs easily exceed $500,000 per year for even the smallest of the small cap companies, to include annual audits, quarterly reviews, legal fees, audit committee fees, SOX compliance costs, annual registration fees and increased insurance premiums for director and officer liability. Oftentimes, boards find that the incremental costs of the public listing outweigh the benefits. Companies often site cost savings as a significant factor in going dark. Saving precious capital is a legitimate reason, but it has a downside."

big boards cost c 185k/yr just to list

most otc co's have decided they cannot even afford the otc $10k news disclosure surcharge(plus other charges) to list on the otcqb-

thus, in 2014-2015, when otc raised the otcqb listing surcharge to 10k/yr =along w other more restrictive changes, many hundreds to thousands of formerly otcqb co's downlisted to the pinks-leaving only ca 1k co's on the otcqb,whereas there are ca 7000-9000 companies on the pinks

the tradeoff is often whether to go belly up or go dark- paying the few specialized loan shark companies for exorbitant loans is a well known death spiral-which NNLX has wisely avoided

the money NNLX has saved since 2014 etc via its present otc classification has allowed NNLX to survive-another long told me years ago NNLX had looked at the requirements to upgrade or uplist -and the requirements were "44 pages long".

there are other reasons for being dark also- in 2009 a new political leader who decided business must be destroyed -bc "all business is evil" (saw the sympathetic liberal doc on a liberal station myself)- politicized the stock market and its regulatory and semi reg agencies with unprecedented unconstitutional orders
to destroy otc co's (since he discovered big co's had too much legal political and eco clout to destroy)-
so thousands of otc co's had their stock illegally restricted without notice

-barring longs w any size position from selling while brokers, mm's and others shorted the stocks to .0001-an illegal never before seen private/public eminent domain scheme against innocent 3rd party purchasers which destroyed many co's and many longs,costing my best friend his life and i lost scores of thousands also.

due to the political pressure to destroy otc stocks-esp the most defenseless low pennies- otc was -either officially or unofficially- greenlighted to impose many new restrictions,which forced many co's to downlist and prevented other co's from uplisting
see my post on wolv re this

i was in a limited info otc co which had an on the ground breakthrough which resulted in rapidly increasing pps - so otc slapped the kiss of death skull and bones on the co.
I personally called otc to find out why. They said they did so bc they assumed xxxx co was running a large promotion- otc does not allow non-pink current co's to run promos-so without any investigation they just slapped the skull and bones for promotional activity.
Under the then hostile to business political environment otc and reg orgs were reportedly given free reign to do just about anything to restrict otc co's.

nobody knows exactly what constitutes a promo in otc's eyes- esp as the political environment changes- but PR's may be interpreted by otc as a promo at their pleasure.
I wouldnt be surprised if otc sent letters to all non current otc classes re this. That may be a reason, besides costs of PR's, why NNLX doesnt use PR's now.

Its even possible the same rationale applies to reporting financials on a web site --if a co isnt current class or higher.
its the carrot and stick- which sometimes boils down to this- either pay us our self set fees to post at a certain classification according to our rules or we will block you from providing info via other methods via the threat of the skull and bones for promo activity.

I'm greatful otc has created the forum to inform investors and in many cases increase transparency but these political and financial reasons often work against transparency also when many thousands of companies cant afford to upgrade to pink current or uplist to the otcqb etc.

otc is for profit public corp which receives c 40% or more of its revenues from the fees they charge co's for their otc postings-the higher the class -the greater the fees
other reasons why NNLX may not upgrade or up-list at this time-besides the sometimes hefty costs to do so-is the nature of the biotech business -one of the most secretive industries replete with very restrictive NDA's, which no doubt tie NNLX's hands. Even SEC reporting co's filings restrict what info is available due to trade secrets and NDA's.






1

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 3

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 3

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Montana Dreams: Faith in New Beginnings

Updated Category News Views 3

Kickstart into a Faith-Fueled Tale Out of Lillington, N.C. comes a novel that isn't just pages of printed text, but almost a life lesson wrapped in fiction. Lee Jennings serves up "Home in Montana," a Christian romance mystery that throws a kaleidoscope of emotions onto the reader's lap, whether they're relaxed in a recliner or flipping through it on their lunch break....

Continue Reading
CME Group Smashes FX Open Interest Record Again

Updated Category News Views 2

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Lab Glassware Market Set for Steady Growth by 2031

Updated Category News Views 0

When you dive into the world of laboratory glassware, it might look like it's all pipettes and test tubes, but there's more bubbling under the surface. This market's got its eyes on a neat little climb from $7,630 million in 2026 to a forecasted $9,170 million by 2031. Ain't just speculation—this one's solid muscle growing at a comfortable 4.0% compound annual growth...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 3

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Updated Category News Views 2

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 2

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 1

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
VEVOR Unveils New Products at IFA Berlin 2026

Updated Category News Views 1

VEVOR's Bold Display at IFA Berlin VEVOR isn't shy about making waves at IFA Berlin 2026. The global home improvement heavyweight decided to go all out with an interactive booth that's hard to miss, giving visitors a real taste—sometimes literally—of what they’ve got to offer. This hands-on approach isn't just a gimmick; it’s a clever move to solidify VEVOR's...

Continue Reading

Top 5 Most Recently Viewed Articles

PTC Therapeutics Conference Call Details for Q2 Financials

Updated Category News Views 138

PTC Therapeutics to Host a Conference Call PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that it will hold a conference call to discuss its financial results for the second quarter of 2025 and provide insights into the company's business strategies. This important call is scheduled for an upcoming Thursday at 4:30 PM Eastern Time. Investors and interested parties...

Continue Reading
Power Nickel Expands Private Placement to Raise C$50 Million

Updated Category News Views 105

Power Nickel Upsizes Private Placement Offering Power Nickel Inc. (NASDAQ: PNPNF), a leading Canadian exploration company, has announced an exciting development regarding its private placement offering. The company has decided to increase the size of its previously announced "best efforts" private placement by an additional C$10 million due to robust demand. This...

Continue Reading
Karyopharm Therapeutics to Showcase Innovative Cancer Solutions

Updated Category News Views 136

Karyopharm Therapeutics to Showcase Innovative Cancer Solutions Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a pharmaceutical company dedicated to developing groundbreaking cancer therapies, is gearing up to participate in an important healthcare event. Their senior management is set to take part in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference....

Continue Reading
Exploring the Future of Toys: Trends for 2026 Unveiled

Updated Category News Views 388

Innovative Toy Trends to Look Out for in 2026 As we enter a new era of play, significant shifts in the toy industry are becoming evident. With technology entwined in our lives more than ever, the upcoming Spielwarenmesse is set to unveil groundbreaking toy trends that reflect the changes in our lifestyles and preferences. Highlighted by the TrendCommittee, the focus is on...

Continue Reading
Red Cat Holdings Secures $4.875 Million Through Warrant Exercise

Updated Category News Views 250

Red Cat Holdings Secures Financial Boost from Warrant Exercise Red Cat Holdings, Inc. (Nasdaq: RCAT) is making headlines with its recent warrant exercise transaction that has led to gross proceeds of $4.875 million. This capital infusion is set to bolster the company's efforts in the dynamic field of drone technology, a sector where Red Cat is rapidly establishing its...

Continue Reading